Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Clinical Breast Cancer|May 21, 2003
The evolving role of capecitabine in breast cancerJoyce A O'ShaughnessySeminars in Oncology|February 7, 2003
Pemetrexed: an active new agent for breast cancerJoyce A O'ShaughnessyClinical Breast Cancer|January 7, 2004
Chemotherapy-induced cognitive dysfunction: a clearer pictureJoyce A O'ShaughnessyThe Surgical Clinics of North America|July 24, 2003
Ductal lavage: clinical utility and future promiseJoyce A O'ShaughnessyClinical Breast Cancer|February 20, 2008
Management of febrile neutropenia and cardiac toxicity in the adjuvant treatment of breast cancerJoyce A O'ShaughnessyClinical Breast Cancer|January 21, 2003
Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapyJoyce A O'ShaughnessyClinical Breast Cancer|January 13, 2004
Pegylated liposomal doxorubicin in the treatment of breast cancerJoyce A O'ShaughnessyClinical Breast Cancer|November 12, 2002
Management of premenopausal women with early-stage breast cancer: is there a role for ovarian suppression?Michael Baum, Joyce A O'ShaughnessyClinical Breast Cancer|June 27, 2007
Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancerMichael S Ewer, Joyce A O'ShaughnessySeminars in Oncology|November 13, 2003
Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applicationsBrian Leyland-Jones, Joyce A O'shaughnessyPageof 7